Britain has granted a conditional authorization to Merck’s coronavirus antiviral. Molnupiravir is the first pill shown to successfully treat COVID-19. Continue reading… Source: WIBX 950
Britain has granted a conditional authorization to Merck’s coronavirus antiviral. Molnupiravir is the first pill shown to successfully treat COVID-19. Continue reading… Source: WIBX 950